Machine learning-based definition of symptom clusters and selection of antidepressants for depressive syndromeopen access
- Authors
- Kim, Il Bin; Park, Seon-Cheol
- Issue Date
- Sep-2021
- Publisher
- MDPI
- Keywords
- Depressive syndrome; Machine learning; Personalized medicine; Selecting antidepressants; Symptom clusters
- Citation
- Diagnostics, v.11, no.9, pp.1 - 13
- Indexed
- SCIE
SCOPUS
- Journal Title
- Diagnostics
- Volume
- 11
- Number
- 9
- Start Page
- 1
- End Page
- 13
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/141021
- DOI
- 10.3390/diagnostics11091631
- Abstract
- The current polythetic and operational criteria for major depression inevitably contribute to the heterogeneity of depressive syndromes. The heterogeneity of depressive syndrome has been criticized using the concept of language game in Wittgensteinian philosophy. Moreover, “a symptom-or endophenotype-based approach, rather than a diagnosis-based approach, has been proposed” as the “next-generation treatment for mental disorders” by Thomas Insel. Understanding the heterogeneity renders promise for personalized medicine to treat cases of depressive syndrome, in terms of both defining symptom clusters and selecting antidepressants. Machine learning algorithms have emerged as a tool for personalized medicine by handling clinical big data that can be used as predictors for subtype classification and treatment outcome prediction. The large clinical cohort data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D), Combining Medications to Enhance Depression Outcome (CO-MED), and the German Research Network on Depression (GRND) have recently began to be acknowledged as useful sources for machine learning-based depression research with regard to cost effectiveness and generalizability. In addition, noninvasive biological tools such as functional and resting state magnetic resonance imaging techniques are widely combined with machine learning methods to detect intrinsic endophenotypes of depression. This review highlights recent studies that have used clinical cohort or brain imaging data and have addressed machine learning-based approaches to defining symptom clusters and selecting antidepressants. Potentially applicable suggestions to realize machine learning-based personalized medicine for depressive syndrome are also provided herein.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 정신건강의학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/141021)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.